Alteration of Inflammatory Parameters and Psychological Post-Traumatic Syndrome in Long-COVID Patients
Overview
Public Health
Affiliations
The aim of our study is to evaluate the correlation between the psychological status of patients recovered from SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection (long-COVID patients) and their inflammatory status. Three months after hospital discharge, ninety-three patients were recruited and categorized into two distinct populations: control and long-COVID (COrona VIrus Disease) group. Patients belonging to the control group presented with an entering diagnosis of cardiovascular, metabolic, or respiratory disease and a negative history of SARS-CoV-2 infection, whereas the long-COVID population presented with a severe SARS-CoV-2 infection treated in the sub-intensive Care Unit. Psychological evaluation was performed through the administration of the Symptom Checklist-90 (SCL90) and LDH (Lactate dehydrogenase), ferritin, CRPhs (C-high sensitivity Reactive Protein), NLR (Neutrophil-to-lymphocyte ratio), PLR (Platelet-to-lymphocyte ratio), and SII (systemic immune-inflammation index) were investigated. We highlighted that beyond the first three months after contagion, patients recovered from SARS-CoV-2 infection are characterized by the persistence of a systemic inflammatory state and are at high risk for developing somatization, depression, anxiety, and sleep disturbances. Interestingly, ferritin value was strongly correlated with sleep disorders (p < 0.05). Our study emphasizes how COVID-19 strategies for risk stratification, prognosis, and therapy management of patients should be implemented with a psychological follow-up.
Bidhendi-Yarandi R, Biglarian A, Karlstad J, Moe C, Bakhshi E, Khodaei-Ardakani M PLoS One. 2025; 20(1):e0312351.
PMID: 39874315 PMC: 11774403. DOI: 10.1371/journal.pone.0312351.
Chen D, Li X, Xiao C, Xiao W, Lou L, Gao Z Int Urol Nephrol. 2024; 57(3):989-997.
PMID: 39527314 PMC: 11821688. DOI: 10.1007/s11255-024-04276-2.
Seighali N, Abdollahi A, Shafiee A, Amini M, Teymouri Athar M, Safari O BMC Psychiatry. 2024; 24(1):105.
PMID: 38321404 PMC: 10848453. DOI: 10.1186/s12888-023-05481-6.
Kadier K, Dilixiati D, Ainiwaer A, Liu X, Lu J, Liu P BMC Psychiatry. 2023; 23(1):773.
PMID: 37872570 PMC: 10594811. DOI: 10.1186/s12888-023-05286-7.
Yamamoto Y, Otsuka Y, Tokumasu K, Sunada N, Nakano Y, Honda H J Clin Med. 2023; 12(14).
PMID: 37510852 PMC: 10381392. DOI: 10.3390/jcm12144737.